Cytarabine (Cytarabine) - News

News related to Cytarabine and/or conditions it is approved for

Despite Promising Laboratory Data Bone Cancer Treatment Ineffective
Source: Bones / Orthopaedics News From Medical News Today [2008.11.11]
Ewing sarcoma is the second most common type of primary bone cancer seen in children and young adults. Patients with relapsed or refractory Ewing sarcoma have a poor outcome with conventional therapies. Cytarabine decreases the levels of a certain key protein in Ewing sarcoma cells and has demonstrated preclinical activity against Ewing sarcoma cell lines in the laboratory. Treatment of Ewing sarcoma that relapses is difficult.